ESI To File Virtual Electrogram Coronary Mapping Device 510(k) This Quarter
This article was originally published in The Gray Sheet
Endocardial Solutions, Inc. (ESI) expects to obtain 510(k) approval by year-end for use of the Ensite 3000 catheter system in mapping the right coronary atrium, President and CEO James Bullock told investors April 27 at the Volpe Brown Whelan & Co. health care conference in New York City.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.